China Pharma Holdings (CPHI) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2016)

China Pharma Holdings (CPHI) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2016) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 52.55%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 6.07%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.19%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -46.43%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 64.08%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -19.39%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -16.96%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -100.00%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 260.88%
10 China Pharma Holdings 18.87 Mn 18.70 Mn 285,487.00 -

Historic Data

Download Data
DateValue
Sep 30, 2016 7.17%
Jun 30, 2016 15.66%
Mar 31, 2016 12.64%
Dec 31, 2015 -91.29%
Sep 30, 2015 32.64%
Jun 30, 2015 -9.14%
Mar 31, 2015 -51.83%
Dec 31, 2014 -97.18%
Sep 30, 2014 -49.83%
Jun 30, 2014 -54.20%
Mar 31, 2014 -34.20%
Dec 31, 2013 -53.26%
Sep 30, 2013 -33.08%
Jun 30, 2013 -39.49%